The time has come! SpaceX has finally revealed images of the Falcon Heavy. Will Goodman, Managing Editor at Rockets are Cool, joins Cheddar to discuss what January looks like for the aerospace company.
The Falcon Heavy has 50% less thrust than the Saturn V, which brought astronauts to the moon, but will have much more power. It will run on 92% force instead of 100%, so the landing of its three rockets will hopefully be smooth. Goodman says it will be like watching Cirque du Soleil show.
Plus, the race to get a man into space could be approaching the finish line. Blue Origin, Jeff Bezos' aerospace company, announced it will send a man to space in the next year and a half. Goodman says that will most likely not happen in the allotted timeframe, but does say that 2018 will be a big year for the Elon Musk-Jeff Bezos-Richard Branson competition.
Australia’s Great Barrier Reef is spawning in an explosion of color as the World Heritage-listed natural wonder recovers from life-threatening coral bleaching episodes.
Climate change that may have contributed to a lobster boom in Maine could soon lead to a bust. Chloe Aiello reports.
Good Morning America co-host Michael Strahan will be among the crew on Blue Origin’s next flight to space.
President Joe Biden is ordering a record-setting 50 million barrels of oil released from America's strategic reserve to help bring down energy costs.
All the news you Need2Know for Tuesday, November 23, 2021.
The U.S. is moving to open up COVID-19 booster shots to all adults, letting them choose another dose of either the Pfizer or Moderna vaccine.
U.S. health officials say an estimated 100,000 Americans died of drug overdoses in one year. That's a total the nation has never seen.
Russian officials on Tuesday rejected accusations that they endangered astronauts aboard the International Space Station by conducting a weapons test that created more than 1,500 pieces of space junk.
Austria has taken what its leader called the “dramatic” step of implementing a nationwide lockdown for unvaccinated people who haven’t recently had COVID-19.
Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market.
